SCM12: Role of cyclophosphamide in ANCA-associated vasculitis

Role of Cyclophosphamide in ANCA-associated vasculitis
Carol Langford, MD (Clevelend Clinic)
Thursday 5/10/12
If you’re not careful, you could fall into a trap and think that Cyclophosphomide (CYC) has such a bad “rep” that is should not be used in ANCA-associated vasculitides (specifically GPA).  Dr. Langford gave a great talk explaining when CYC should be used.  Though CYC has a number of toxic effects, it is still considered a “go to” medication for *severe* GPA disease.  Unfortunately, we never walked away with a strict definition of what *severe* is, but presumably this would mean high creatinine, crescentic GN, and/or diffuse alveolar hemorrhage (+/- the need for mechanical ventilation).  CYC has a great track record of inducing remission, and both the IV and PO forms seem to be equally effective at achieving induction. The choice of using PO or IV forms will depend on the physician and the patient, as the former has a lower rate of relapse but the latter has a lower rate of infectious complications (though neither difference is so significant as to allow her to make a definitive recommendation of one route versus another).  However, it appears that both IV and PO forms will need to be followed by a maintenance drug, either a) methotrexate (MTX), b) azathioprine (AZA), or c) mycophenolate (MMF).  Regarding MTX versus AZA, both are equally well at maintaining remission, though some would consider using MTX if the disease is not too severe.  Unfortunately, the story isn’t the same for MMF versus AZA, where the former is less superior at maintaining remission (38% versus 55%, p 0.03).

Check back for more eAJKD coverage of SCM12! Also, check out @eAJKD on Twitter for live updates of SCM12!

1 Trackback / Pingback

  1. Recap of eAJKD’s coverage of the NKF 2012 Spring Clinical Meetings –

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s